5:26 PM ET
8-K
Nasdaq/NYSE Compliance Notice
Calidi Biotherapeutics Nasdaq/NYSE Compliance Notice
Calidi Biotherapeutics received a deficiency notice from NYSE American for failing to maintain the minimum stockholders' equity requirement of $4.0 million. The company reported stockholders' equity of $3.1 million as of June 30, 2026, and has until October 21, 2026, to submit a plan to regain compliance by March 21, 2028.
- Counterparty
- NYSE American LLC
- Term
- through March 21, 2028